Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Metabolic Syndrome and Preeclampsia.

Hooijschuur MCE, Ghossein-Doha C, Kroon AA, de Leeuw PW, Zandbergen AAM, van Kuijk SMJ, Spaanderman MEA.

Ultrasound Obstet Gynecol. 2018 Sep 23. doi: 10.1002/uog.20126. [Epub ahead of print]

PMID:
30246464
2.

Use of monomeric and oligomeric flavanols in the dietary management of patients with type 2 diabetes mellitus and microalbuminuria (FLAVA trial): study protocol for a randomized controlled trial.

Rashid M, Verhoeven AJM, Mulder MT, Timman R, van Beek-Nieuwland Y, Athumani AA, Zandbergen AAM, van der Wiel HE, Sijbrands EJG, Berk KA.

Trials. 2018 Jul 16;19(1):379. doi: 10.1186/s13063-018-2762-9.

3.

Prediabetes and macrovascular disease: Review of the association, influence on outcome and effect of treatment.

Kleinherenbrink W, Osei E, den Hertog HM, Zandbergen AAM.

Eur J Intern Med. 2018 Sep;55:6-11. doi: 10.1016/j.ejim.2018.07.001. Epub 2018 Jul 12. Review. No abstract available.

PMID:
30007840
4.

Impaired fasting glucose is associated with unfavorable outcome in ischemic stroke patients treated with intravenous alteplase.

Osei E, Fonville S, Zandbergen AAM, Koudstaal PJ, Dippel DWJ, den Hertog HM.

J Neurol. 2018 Jun;265(6):1426-1431. doi: 10.1007/s00415-018-8866-z. Epub 2018 Apr 17.

PMID:
29666986
5.

Admission Glucose and Effect of Intra-Arterial Treatment in Patients With Acute Ischemic Stroke.

Osei E, den Hertog HM, Berkhemer OA, Fransen PSS, Roos YBWEM, Beumer D, van Oostenbrugge RJ, Schonewille WJ, Boiten J, Zandbergen AAM, Koudstaal PJ, Dippel DWJ; MR CLEAN Investigators.

Stroke. 2017 May;48(5):1299-1305. doi: 10.1161/STROKEAHA.116.016071. Epub 2017 Apr 7.

PMID:
28389610
6.

Increased admission and fasting glucose are associated with unfavorable short-term outcome after intra-arterial treatment of ischemic stroke in the MR CLEAN pretrial cohort.

Osei E, den Hertog HM, Berkhemer OA, Fransen PS, Roos YB, Beumer D, van Oostenbrugge RJ, Schonewille WJ, Boiten J, Zandbergen AA, Koudstaal PJ, Dippel DW; MR CLEAN pretrial investigators.

J Neurol Sci. 2016 Dec 15;371:1-5. doi: 10.1016/j.jns.2016.10.003. Epub 2016 Oct 6.

PMID:
27871427
7.

Glucose in prediabetic and diabetic range and outcome after stroke.

Osei E, Fonville S, Zandbergen AA, Koudstaal PJ, Dippel DW, den Hertog HM.

Acta Neurol Scand. 2017 Feb;135(2):170-175. doi: 10.1111/ane.12577. Epub 2016 Feb 26.

PMID:
26918555
8.

Metformin and sitAgliptin in patients with impAired glucose tolerance and a recent TIA or minor ischemic Stroke (MAAS): study protocol for a randomized controlled trial.

Osei E, Fonville S, Zandbergen AA, Brouwers PJ, Mulder LJ, Lingsma HF, Dippel DW, Koudstaal PJ, den Hertog HM.

Trials. 2015 Aug 5;16:332. doi: 10.1186/s13063-015-0882-z.

9.

Prediabetes in patients with stroke or transient ischemic attack: prevalence, risk and clinical management.

Fonville S, Zandbergen AA, Koudstaal PJ, den Hertog HM.

Cerebrovasc Dis. 2014;37(6):393-400. doi: 10.1159/000360810. Epub 2014 Jun 28. Review.

10.

Occurrence and predictors of persistent impaired glucose tolerance after acute ischemic stroke or transient ischemic attack.

Fonville S, den Hertog HM, Zandbergen AA, Koudstaal PJ, Lingsma HF.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1669-75. doi: 10.1016/j.jstrokecerebrovasdis.2014.01.012. Epub 2014 Apr 13.

PMID:
24725814
11.

Nephrocalcinosis as adult presentation of Bartter syndrome type II.

Huang L, Luiken GP, van Riemsdijk IC, Petrij F, Zandbergen AA, Dees A.

Neth J Med. 2014 Feb;72(2):91-3.

12.

Bilateral axillary arterial obstruction.

van der Matten B, Zandbergen AA, Dees A.

BMJ Case Rep. 2014 Jan 22;2014. pii: bcr2013201745. doi: 10.1136/bcr-2013-201745.

13.

Prevalence of prediabetes and newly diagnosed diabetes in patients with a transient ischemic attack or stroke.

Fonville S, Zandbergen AA, Vermeer SE, Dippel DW, Koudstaal PJ, den Hertog HM.

Cerebrovasc Dis. 2013;36(4):283-9. doi: 10.1159/000353677. Epub 2013 Oct 16.

PMID:
24135458
14.

Safety and feasibiLIty of Metformin in patients with Impaired glucose Tolerance and a recent TIA or minor ischemic stroke (LIMIT) trial - a multicenter, randomized, open-label phase II trial.

den Hertog HM, Vermeer SE, Zandbergen AA, Achterberg S, Dippel DW, Algra A, Kappelle LJ, Koudstaal PJ.

Int J Stroke. 2015 Jan;10(1):105-9. doi: 10.1111/ijs.12023. Epub 2013 Mar 15.

PMID:
23489282
15.

Vitamin D deficiency in patients with erythropoietic protoporphyria.

Spelt JM, de Rooij FW, Wilson JH, Zandbergen AA.

J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S1-4.

PMID:
24137761
16.

High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa.

de Vries JM, van der Beek NA, Kroos MA, Ozkan L, van Doorn PA, Richards SM, Sung CC, Brugma JD, Zandbergen AA, van der Ploeg AT, Reuser AJ.

Mol Genet Metab. 2010 Dec;101(4):338-45. doi: 10.1016/j.ymgme.2010.08.009. Epub 2010 Aug 14.

PMID:
20826098
17.

Low bone mass in Pompe disease: muscular strength as a predictor of bone mineral density.

van den Berg LE, Zandbergen AA, van Capelle CI, de Vries JM, Hop WC, van den Hout JM, Reuser AJ, Zillikens MC, van der Ploeg AT.

Bone. 2010 Sep;47(3):643-9. doi: 10.1016/j.bone.2010.06.021. Epub 2010 Jun 25.

PMID:
20601298
18.

Using heparin therapy to reverse protein-losing enteropathy in a patient with CDG-Ib.

Liem YS, Bode L, Freeze HH, Leebeek FW, Zandbergen AA, Paul Wilson J.

Nat Clin Pract Gastroenterol Hepatol. 2008 Apr;5(4):220-4. doi: 10.1038/ncpgasthep1061. Epub 2008 Feb 19.

PMID:
18285818
19.

Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria.

Zandbergen AA, Vogt L, de Zeeuw D, Lamberts SW, Ouwendijk RJ, Baggen MG, Bootsma AH.

Diabetes Care. 2007 Dec;30(12):3119-21. Epub 2007 Sep 5. No abstract available.

PMID:
17804682
20.

Normotensive women with type 2 diabetes and microalbuminuria are at high risk for macrovascular disease.

Zandbergen AA, Sijbrands EJ, Lamberts SW, Bootsma AH.

Diabetes Care. 2006 Aug;29(8):1851-5.

PMID:
16873791

Supplemental Content

Loading ...
Support Center